Skip to main content
Clinical Trials/JPRN-jRCT1030220201
JPRN-jRCT1030220201
Completed
Phase 1

Attention deficit/hyperactive disorder (ADHD) in the homeApplication of Neurofeedback Training (NFT)

Tazaki Miyako0 sites8 target enrollmentJuly 8, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
ADHD
Sponsor
Tazaki Miyako
Enrollment
8
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 8, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Tazaki Miyako

Eligibility Criteria

Inclusion Criteria

  • 8 to 10 year old who has been diagnosed with ADHD at the start of the study, or is troubled by problem behaviors at home or at school due to a lack of attention or behavior control. At the same time, parents should have a PC at home and be able to interact with researchers online, send data, and conduct training for their children twice a week.

Exclusion Criteria

  • The participant who has prescribed medication for ADHD, or diagnosed leaky intestinal syndrome, epilepsy or brain injury, intellectual and developmental disabilities, self\-harm, etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
N/A
Attention Deficit Hyperactivity Disorder (ADHD) and opioid maintenance therapy.A randomized, placebo-controlled study of the efficacy of atomoxetine for treating adult ADHD in patients receiving opioid maintenance therapyPatients will be recruited from out-patient clinics treating opioid dependent patients with buprenorphine or methadone maintenance therapy. Patients will be screened for ADHD symptoms. Based on the screen results, patients will undergo medical and psychiatric assessment to identify those meeting the criteria for adult ADHD. Patients diagnosed with comorbid ADHD and opioid dependence will then be randomized into atomoxetine and placebo study groups.MedDRA version: 12.1Level: LLTClassification code 10064104Term: ADHD
EUCTR2010-019981-94-FIHUS/ Neuropsykiatrian poliklinikka30
Completed
N/A
Attention deficit hyperactivity disorder, developmental coordination disorder, and the cognitive orientation to daily occupational performance approach: Is there a role for diagnostic profiling and treatment to improve mental health outcomes?Attention Deficit Hyperactivity DisorderDevelopmental Coordination DisorderMental Health - Other mental health disordersPhysical Medicine / Rehabilitation - Occupational therapy
ACTRN12618001972213a Trobe University19
Not Yet Recruiting
Phase 3
Identification of Attention Deficit Hyperactivity Disorder using Parent-Teacher administered ADHD Rating Scale-IV among Pre-school going children to know the prevalence of this disorder in Belagavi city.
CTRI/2023/07/054991KAHER Institute Of Physiotherapy
Recruiting
Phase 2
Attention Defficity Hyperactivity Disorder and fMRI neurofeedback: A randomized controlled trial on the effects of self-modulating anterior cingulate cortex activation levels.
NL-OMON37512niversitair Medisch Centrum Sint Radboud
Completed
Phase 3
Imaging the influence and interaction of genes and stimulant medication on attention in Attention Deficit Hyperactivity Disorder (ADHD).
ACTRN12610000652077Dr. Tim Silk36